Pascal Soriot

Pascal Soriot

business executiveMale0.0Global Dominance: 0.00%

Pascal Soriot is the chief executive of AstraZeneca, known for his leadership during the COVID-19 pandemic and his role in the recent cancellation of a significant investment in vaccine production in the UK, citing unmet financial support requirements.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Pascal Soriot stated that AstraZeneca is recording strong commercial results across all therapeutic areas.

AstraZeneca bilježi rast prodaje i najavljuje ambiciozne cijene do 2030
Vijesti – largest independent Montenegrin daily, est. 1997·MontenegroMontenegro· 2026-02-13
9.0

Pascal Soriot is the CEO of AstraZeneca and has emphasized the need for Europe to protect its health sovereignty.

Zdravljenje kroničnih nenalezljivih bolezni zahteva hitre in preventivne ukrepe
Delo – major Slovenian daily, est. 1959·SloveniaSlovenia· 2025-12-03
8.0

Pascal Soriot is the CEO of AstraZeneca who secured a medicine deal with U.S. President Donald Trump.

How AstraZeneca sealed a US medicine deal with Trump
Stabroek News·GuyanaGuyana· 2025-10-14
8.0

AstraZeneca CEO Pascal Soriot said that during tough negotiations to reach a deal, Trump and his team had 'really kept me up at night'.

AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs | US healthcare
The Guardian·United KingdomUnited Kingdom· 2025-10-11
5.0

Pascal Soriot is the global CEO of AstraZeneca and has expressed the company's commitment to investing in China.

【决胜“十四五”】高水平对外开放,提速升级 _光明网
Guangming Daily·ChinaChina· 2025-10-09
8.0

AstraZeneca boss Pascal Soriot announced the firm's $50bn investment in the US in July.

AstraZeneca pauses £200m Cambridge investment
BBC·United KingdomUnited Kingdom· 2025-09-12
6.0

Pascal Soriot is the CEO of pharmaceutical giant AstraZeneca and earned £14.7 million last fiscal year.

Platy šéfov veľkých britských firiem vzrástli na nový rekord
SME – major Slovak daily, est. 1993·SlovakiaSlovakia· 2025-08-18
9.0
Also mentioned
Peter Dilnot
Peter Dilnot

Pascal Soriot is the CEO of AstraZeneca and has supported Trump's demands regarding drug pricing.

Roche-Präsident Schwan zwischen Trump und Standort Schweiz
Neue Zürcher Zeitung·SwitzerlandSwitzerland· 2025-08-13
6.0

Pascal Soriot, the chief executive of AstraZeneca, has emphasized the importance of the US to the company.

AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom | AstraZeneca
The Guardian·United KingdomUnited Kingdom· 2025-07-29
8.0

The AstraZeneca chief executive, Pascal Soriot, said the $50bn investment would support the company’s ambition to reach $80bn in revenue by 2030.

AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats | AstraZeneca
The Guardian·United KingdomUnited Kingdom· 2025-07-22
8.0

Pascal Soriot is the CEO of AstraZeneca and emphasizes the need for Europe to protect its health sovereignty.

Vrsta bolezni, zaradi katere umre 41 milijonov ljudi na leto
Delo – major Slovenian daily, est. 1959·SloveniaSlovenia· 2025-06-09
8.0

Pascal Soriot, the CEO of AstraZeneca, has called on Europe to strengthen its 'health sovereignty'.

Novartis in drugi farmacevtski velikani pozivajo k višjim cenam zdravil v EU
Delo – major Slovenian daily, est. 1959·SloveniaSlovenia· 2025-04-24
6.0

AstraZeneca’s chief executive, Pascal Soriot, was also in the audience at a business forum in Beijing.

China needs friends in Trump’s trade war. But Xi may have to go it alone | Global economy
The Guardian·United KingdomUnited Kingdom· 2025-04-05
5.0

Pascal Soriot, the CEO of AstraZeneca, expressed commitment to investing in a world-class innovation ecosystem in China.

“硬数据”与“软环境”(望海楼) --观点--人民网
People's Daily·ChinaChina· 2025-03-28
8.0

Pascal Soriot of AstraZeneca PLC participated in the meeting with Xi Jinping.

Xi meets global business leaders
Taipei Times – major English newspaper in Taiwan, est. 1999·TaiwanTaiwan· 2025-03-28
7.0

AstraZeneca chief executive Pascal Soriot announced plans for the pharmaceuticals giant to invest $US2.5 billion into a new research and development facility in the Chinese capital.

The Trump turmoil has handed China a golden opportunity
The Sydney Morning Herald·AustraliaAustralia· 2025-03-25
6.0

Pascal Soriot from AstraZeneca is participating in the forum with other foreign executives.

Китайський прем'єр закликав до вільної торгівлі
Українська правда (Ukrayinska Pravda)·UkraineUkraine· 2025-03-23
7.0

Pascal Soriot, the chief executive of AstraZeneca, stated that the $2.5bn investment reflects their belief in the life sciences ecosystem in Beijing.

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing | AstraZeneca
The Guardian·United KingdomUnited Kingdom· 2025-03-22
9.0
Also mentioned
Leon Wang
Leon Wang

AstraZeneca’s Pascal Soriot is attending the China Development Forum.

In the Trump era, Europe should shift its gaze towards China – Joseph Stiglitz – The Irish Times
The Irish Times – major Irish daily, est. 1859·IrelandIreland· 2025-03-21
6.0